MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,356,000 | -18.3% | 77,000 | 0.0% | 0.51% | -14.9% |
| Q1 2016 | $2,882,000 | -13.3% | 77,000 | 0.0% | 0.60% | -9.6% |
| Q4 2015 | $3,323,000 | +15.1% | 77,000 | 0.0% | 0.67% | +18.2% |
| Q3 2015 | $2,886,000 | +10.3% | 77,000 | 0.0% | 0.56% | +21.5% |
| Q2 2015 | $2,617,000 | -4.0% | 77,000 | 0.0% | 0.46% | -3.1% |
| Q1 2015 | $2,726,000 | +45.5% | 77,000 | +40.0% | 0.48% | +36.4% |
| Q4 2014 | $1,873,000 | +98.0% | 55,000 | +120.0% | 0.35% | +79.6% |
| Q3 2014 | $946,000 | – | 25,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |